Cargando…
Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa
BACKGROUND: Little is known about treatment of multidrug-resistant tuberculosis (MDR-TB) in high HIV-prevalence settings such as sub-Saharan Africa. METHODOLOGY/PRINCIPAL FINDINGS: We did a retrospective analysis of early outcomes of the first cohort of patients registered in the Lesotho national MD...
Autores principales: | Seung, Kwonjune J., Omatayo, David B., Keshavjee, Salmaan, Furin, Jennifer J., Farmer, Paul E., Satti, Hind |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746313/ https://www.ncbi.nlm.nih.gov/pubmed/19779624 http://dx.doi.org/10.1371/journal.pone.0007186 |
Ejemplares similares
-
Extensively Drug-Resistant Tuberculosis, Lesotho
por: Satti, Hind, et al.
Publicado: (2008) -
Outcomes of Comprehensive Care for Children Empirically Treated for Multidrug-Resistant Tuberculosis in a Setting of High HIV Prevalence
por: Satti, Hind, et al.
Publicado: (2012) -
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
por: Khan, Uzma, et al.
Publicado: (2019) -
Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa
por: Cox, Helen S., et al.
Publicado: (2010) -
‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)